Capstone Therapeutics Announces Results of Special Shareholder Meeting, and a License Transfer/Royalty Agreement and Exit from the Pharmaceutical Development Business
ALSIP, IL / ACCESSWIRE / February 18, 2021 / Capstone Therapeutics (OTCQB:CAPS) (“the Company”) On…
MiMedia Holdings Inc. Announces June 30th Interest Payment on Convertible Debentures to be Settled in Subordinate Voting Shares
CEO.CA’s Inside the Boardroom: Enduro Metals is Drilling Soon in the Heart of the Golden Triangle
WISR AI Systems Provides Corporate Update and Announces Non-Brokered Private Placement
NordVPN confirms 96% phishing detection and a new dedicated server feature